{"id":"NCT04967508","sponsor":"Samsung Bioepis Co., Ltd.","briefTitle":"A Study to Compare SB17 (Proposed Ustekinumab Biosimilar) to Stelara® in Subject With Moderate to Severe Plaque Psoriasis","officialTitle":"A Phase III, Randomised, Double-blind, Multicentre Clinical Study to Evaluate the Efficacy, Safety, Tolerability, Pharmacokinetics, and Immunogenicity of SB17 (Proposed Ustekinumab Biosimilar) Compared to Stelara® in Subjects With Moderate to Severe Plaque Psoriasis","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2021-07-06","primaryCompletion":"2022-02-24","completion":"2022-11-25","firstPosted":"2021-07-19","resultsPosted":"2025-05-25","lastUpdate":"2025-05-25"},"enrollment":503,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Psoriasis","Moderate to Severe Plaque Psoriasis"],"interventions":[{"type":"DRUG","name":"Stelara® (Ustekinumab)","otherNames":[]},{"type":"DRUG","name":"SB17 (Proposed Ustekinumab Biosimilar)","otherNames":[]}],"arms":[{"label":"SB17 (Proposed Ustekinumab Biosimilar)","type":"EXPERIMENTAL"},{"label":"Stelara® (Ustekinumab)","type":"ACTIVE_COMPARATOR"}],"summary":"This is a randomised, double-blind, multicentre clinical study to evaluate the efficacy, safety, tolerability, PK, and immunogenicity of SB17 compared to Stelara® in subjects with moderate to severe plaque psoriasis.","primaryOutcome":{"measure":"Percent Change From Baseline in PASI at Week 12","timeFrame":"Baseline and Week 12","effectByArm":[{"arm":"SB17 (Proposed Ustekinumab Biosimilar)","deltaMin":85.7,"sd":2.53},{"arm":"Stelara (Ustekinumab)","deltaMin":86.3,"sd":2.41}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":7,"exclusionCount":17},"locations":{"siteCount":32,"countries":["Czechia","Estonia","Hungary","Latvia","Lithuania","Poland","South Korea","Ukraine"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":7,"n":249},"commonTop":["COVID-19","Nasopharyngitis","Upper respiratory tract infection"]}}